Breast Cancer :: No higher risk from breast cancer gene

Breast cancer patients who possess one of the so-called “breast cancer” or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.

Breast Cancer :: Src inhibitors may prove beneficial in breast cancer therapy

Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alpha?negative cancers are more aggressive and have a worse prognosis than do ER-alpha?positive breast cancers, and have been thought to be estrogen independent.

Breast Cancer :: Racial differences in severity of breast cancer presentation confirmed

African-American women are diagnosed with more advanced breast cancer than Caucasians, according to a new, single hospital study. Published in the August 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study analyzed demographic and breast cancer data from a single institution?s registry, and confirmed that African-Americans are more likely to present with later stage and higher grade tumors compared to Caucasians.

Breast Cancer :: $2 million Komen Award will fund research to reduce risk of breast cancer

Now that screening for genes that predispose a woman to breast cancer is routinely available, women at an increased risk are looking for ways to keep themselves healthy. Insoo Bae, PhD, a junior faculty member of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center received a $2 million research award from Susan G. Komen for the Cure to do just that.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack